Skip to content

PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s disease

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505471-78-00
Acronym
D9690C00004
Enrollment
14
Registered
2023-08-31
Start date
2023-09-25
Completion date
2024-10-08
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease

Interventions

None listed

Sponsors

Astrazeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026